Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
SOLEUS CAPITAL MANAGEMENT LP | 08-14-2024 | 06-30-2024 | 92 | 1,133,962,902 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
NOVOCURE LTD | ORD SHS | 201 | $1,865,457 | 108,900 | 0.00 | 0.00 | -586,859 | -84.35 | 06-30-2024 |
APOGEE THERAPEUTICS INC | COM | Liquidated | $0 | 0 | 0.00 | 0.00 | -15,000 | -42.86 | 06-30-2024 |
INHIBRX BIOSCIENCES INC | COM | 203 | $1,253,620 | 88,470 | 0.00 | 88,470 | +Inf | 06-30-2024 | |
TRANSMEDICS GROUP INC | COM | Liquidated | $0 | 0 | 0.00 | 16,700 | +Inf | 06-30-2024 |